Dietz Thomas John 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Jan 25, 2023
Insider Transaction Report
Form 4
Dietz Thomas John
Director
Transactions
- Purchase
Common Stock
2023-01-23$1.43/sh+50,000$71,580→ 50,000 total(indirect: By Trust)
Holdings
- 21,000
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- [F2]These shares are held directly by the Dietz Family Trust, for which the reporting person and his spouse serve as co-trustees.